Showing results (211-220 of 260) with videos related to

Sort By:
Pageof 26
Oncogene|May 24, 2000
An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivoC A Midgley, J M Desterro, M K Saville, et al.
Gene Therapy|April 21, 2001
Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53K S Lipinski, A H Djeha, E Krausz, et al.
Oncogene|October 1, 1991
Expression of p53 in premalignant and malignant squamous epitheliumB A Gusterson, R Anbazhagan, W Warren, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990
p53 mutations in colorectal cancerN R Rodrigues, A Rowan, M E Smith, et al.
The Journal of Biological Chemistry|April 19, 1996
Two pathways for base excision repair in mammalian cellsG Frosina, P Fortini, O Rossi, et al.
The Journal of Pathology|October 1, 1991
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fractionR J Scott, P A Hall, J S Haldane, et al.
International Journal of Cancer|September 9, 1991
p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasiaJ Bártková, J Bártek, J Lukás, et al.
Protein Engineering, Design & Selection : PEDS|September 1, 2018
Synthetic 10FN3-based mono- and bivalent inhibitors of MDM2/X functionS-Y Lau, J W Siau, R M Sobota, et al.
Biochemistry|June 20, 2000
A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamicsD I Zheleva, N Z Zhelev, P M Fischer, et al.
Oncogene|November 1, 1993
Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinomaA C Williams, S J Browne, W A Yeudal, et al.
Pageof 26